In vitro effects of amphotericin B on growth and ultrastructure of the amoeboflagellates Naegleria gruberi and Naegleria fowleri.

Antimicrobial Agents and Chemotherapy
Frederick L Schuster, E Rechthand

Abstract

In vitro effects of the polyene antibiotic amphotericin B (AmB) on growth, viability, and ultrastructure of amoeboflagellates of the genus Naegleria were examined. The strains studied were the nonpathogenic Naegleria gruberi EG(B) and the Carter and TY strains of the pathogenic Naegleria fowleri. AmB was amoebicidal at all concentrations used (0.25, 0.50, and 1.0 mug/ml) when the drug was added to cultures in lag phase, as determined by viability testing, but was mainly inhibitory when added to log-phase cultures. The drug produced ultrastructural modifications at all concentrations (0.05 to 1.0 mug/ml). These changes included distortion of nuclear shape, increase in cytoplasmic membranes (both rough and smooth endoplasmic reticulum), decrease in number of food vacuoles, absence of pseudopod formation, mitochondrial abnormalities, increase in autophagic vacuoles, and blebbing of the plasma membrane. These alterations of amoebic ultrastructure became more pronounced with increased time in AmB and with increase in AmB concentration in the growth medium.

References

Mar 1, 1975·Journal of General Microbiology·E F GaleT Y Koh
Feb 16, 1974·Lancet·A Jamieson, K Anderson
May 10, 1974·Annals of the New York Academy of Sciences·R W Holz
May 10, 1974·Annals of the New York Academy of Sciences·T E Andreoli
Jan 1, 1972·Transactions of the Royal Society of Tropical Medicine and Hygiene·R F Carter
Oct 1, 1972·Pathology·K Anderson, A Jamieson
Jan 1, 1971·Annual Review of Microbiology·C G Culbertson
Jan 1, 1971·Transactions of the Royal Society of Tropical Medicine and Hygiene·S R Das
Mar 7, 1970·British Medical Journal·J ApleyD C Warhurst
Jun 1, 1971·Annals of Internal Medicine·A P ShapiroE T Scheib
Nov 1, 1974·Antimicrobial Agents and Chemotherapy·A Tärnvik, S Ansehn

❮ Previous
Next ❯

Citations

Feb 1, 1984·International Journal for Parasitology·A FerranteY H Thong
Apr 10, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Frederick L Schuster, Govinda S Visvesvara
May 4, 2005·Trends in Cognitive Sciences·Marta B ManserDorothy L Cheney
Jan 1, 1984·Antimicrobial Agents and Chemotherapy·F L Schuster, N Mandel
Apr 17, 1976·British Medical Journal·D C WarhurstS K Clarke
Aug 18, 2004·International Journal for Parasitology·Frederick L Schuster, Govinda S Visvesvara
Oct 30, 2016·Acta Tropica·Ruqaiyyah SiddiquiNaveed Ahmed Khan
Jul 7, 2016·Journal of Medical Microbiology·Moisés Martínez-CastilloMineko Shibayama
Nov 1, 2016·Parasitology Research·Roberto Cárdenas-ZúñigaMineko Shibayama
Jul 20, 2017·Microbiology·Roberto Cárdenas-ZúñigaMineko Shibayama
Jan 1, 1979·Transactions of the Royal Society of Tropical Medicine and Hygiene·Y H ThongD E O'Keefe
Jun 30, 1975·Annals of the New York Academy of Sciences·C Fulton, J D Kowit
Apr 2, 2009·The Journal of Eukaryotic Microbiology·Bibiana Chávez-MunguíaGuadalupe Ortega-Pierres
Dec 29, 2017·PLoS Neglected Tropical Diseases·Anjan DebnathLarissa M Podust
Nov 27, 2020·FEMS Microbiology Ecology·Leigha M Stahl, Julie B Olson
Mar 1, 1988·Microbiological Reviews·F Marciano-Cabral

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.